193 related articles for article (PubMed ID: 7016323)
41. High-dose etoposide with autologous bone marrow transplantation as initial treatment of small cell lung cancer--a negative report.
Littlewood TJ; Bentley DP; Smith AP
Eur J Respir Dis; 1986 May; 68(5):370-4. PubMed ID: 3015650
[TBL] [Abstract][Full Text] [Related]
42. Total-body irradiation and high-dose teniposide: a pilot study in bone marrow transplantation for patients with relapsed acute lymphoblastic leukemia.
Krance RA; Forman SJ; Blume KG
Cancer Treat Rep; 1987 Jun; 71(6):645-7. PubMed ID: 3555790
[TBL] [Abstract][Full Text] [Related]
43. Combination chemotherapy study for remission maintenance in ALL: an evaluation of vincristine, cyclophosphamide and vincristine, cyclophosphamide, and BCNU: a Southwest Oncology Group Phase II Study.
Sexauer CL; Vietti T; Humphrey GB
Am J Pediatr Hematol Oncol; 1981; 3(3):255-7. PubMed ID: 6945060
[TBL] [Abstract][Full Text] [Related]
44. [VP 16-213 in the treatment of acute leukemia in childhood].
Esumi N; Arakawa S; Imashuku S
Gan To Kagaku Ryoho; 1983 Mar; 10(3):848-51. PubMed ID: 6576730
[TBL] [Abstract][Full Text] [Related]
45. [Intensive treatment and autologous bone marrow transplantation in cases of acute leukemia and lymphoma].
Chapuis B; Helg C; Aapro M; Maurice P; Pipard G; Wyss M
Schweiz Med Wochenschr; 1986 Aug; 116(34):1158-9. PubMed ID: 3532313
[TBL] [Abstract][Full Text] [Related]
46. [High dose combination chemotherapy followed by autologous bone marrow transplantation in a case of acute myelocytic leukemia (author's transl)].
Gorin NC; Stachowiak J; Hirsch-Marie F; David R; Muller JY; Jullien AM; Cavalier J; Salmon C; Najman A; Duhamel G
Nouv Presse Med; 1977 Sep; 6(31):2741-5. PubMed ID: 339194
[No Abstract] [Full Text] [Related]
47. Escalating dose of mitoxantrone with high-dose cyclophosphamide, carmustine, and etoposide in patients with refractory lymphoma undergoing autologous bone marrow transplantation.
Attal M; Canal P; Schlaifer D; Chatelut E; Dezeuze A; Huguet F; Payen C; Pris J; Laurent G
J Clin Oncol; 1994 Jan; 12(1):141-8. PubMed ID: 8270970
[TBL] [Abstract][Full Text] [Related]
48. Treatment of the blast crisis of chronic myelogenous leukemia with 5-azacitidine and VP-16-213.
Schiffer CA; DeBellis R; Kasdorf H; Wiernik PH
Cancer Treat Rep; 1982 Feb; 66(2):267-71. PubMed ID: 6173123
[TBL] [Abstract][Full Text] [Related]
49. [High dose combination chemotherapy with and without autologous bone marrow transplantation in patients with solid tumors and acute leukemias. Kinetics of recovery of peripheral bloods cells (author's transl)].
Gorin NC; Najman A; David R; Stachowiak J; Hirsch Marie F; Muller JY; Petit JC; Leblanc G; Parlier Y; Jullien AM; Cavalier J; Salmon C; Duhamel G
Nouv Presse Med; 1978 Dec; 7(45):4105-10. PubMed ID: 370764
[No Abstract] [Full Text] [Related]
50. Phase II study of VP-16-213 in childhood malignant disease: a Children's Cancer Study Group Report.
Chard RL; Krivit W; Bleyer WA; Hammond D
Cancer Treat Rep; 1979; 63(11-12):1755-9. PubMed ID: 294306
[TBL] [Abstract][Full Text] [Related]
51. High-dose chemotherapy and unpurged autologous bone marrow transplantation for acute leukemia in second or subsequent remission.
Spinolo JA; Dicke KA; Horwitz LJ; Jagannath S; McCredie K; Estey E; Kantarjian H; Zander AR; Keating M; Spitzer G
Cancer; 1990 Aug; 66(4):619-26. PubMed ID: 2386890
[TBL] [Abstract][Full Text] [Related]
52. High-dose melphalan with or without marrow transplantation: a study of dose-effect in patients with refractory and/or relapsed acute leukemias.
Maraninchi D; Pico JL; Hartmann O; Gastaut JA; Kamioner D; Hayat M; Mascret B; Beaujean F; Sebahoun G; Novakovitch G
Cancer Treat Rep; 1986 Apr; 70(4):445-8. PubMed ID: 3516394
[TBL] [Abstract][Full Text] [Related]
53. [Experiences with VP-16 in combination with cyclophosphamide or adriamycin in the anaplastic, predominantly small cell bronchogenic carcinoma].
Schmieder HA; Jungi WF; Mayr AC; Senn HJ
Schweiz Med Wochenschr; 1979 Jun; 109(22):841-4. PubMed ID: 462156
[TBL] [Abstract][Full Text] [Related]
54. Early pulmonary toxicity after administration of high-dose BCNU.
Litam JP; Dail DH; Spitzer G; Vellekoop L; Verma DS; Zander AR; Dicke KA
Cancer Treat Rep; 1981; 65(1-2):39-44. PubMed ID: 6261949
[TBL] [Abstract][Full Text] [Related]
55. High-dose BCNU therapy with autologous bone marrow infusion: preliminary observations.
Spitzer G; Dicke KA; Verma DS; Zander A; McCredie KB
Cancer Treat Rep; 1979 Aug; 63(8):1257-64. PubMed ID: 383292
[TBL] [Abstract][Full Text] [Related]
56. Chemotherapy with maximally tolerable doses of VP 16-213 and cyclophosphamide followed by autologous bone marrow transplantation for the treatment of relapsed or refractory germ cell tumors.
Mulder PO; de Vries EG; Koops HS; Splinter T; Maas A; van der Geest S; Mulder NH; Sleijfer DT
Eur J Cancer Clin Oncol; 1988 Apr; 24(4):675-9. PubMed ID: 2838293
[TBL] [Abstract][Full Text] [Related]
57. Intermittent continuous iv infusion of high-dose cyclophosphamide for remission induction in acute lymphocytic leukemia.
Solidoro A; Otero J; Vallejos C; Casanova L; Salas F; Pasco T; Quiroz L; Orlandini O; Marcial J
Cancer Treat Rep; 1981; 65(3-4):213-8. PubMed ID: 6940657
[TBL] [Abstract][Full Text] [Related]
58. VP 16-213 and cyclophosphamide in the treatment of refractory acute nonlymphocytic leukemia with monocytic features.
Hurd DD; Peterson BA; McKenna RW; Bloomfield CD
Med Pediatr Oncol; 1981; 9(3):251-5. PubMed ID: 7017368
[TBL] [Abstract][Full Text] [Related]
59. High-dose combination chemotherapy with autologous bone marrow transplantation in adult solid tumors.
Spitzer G; Dicke KA; Litam J; Verma DS; Zander A; Lanzotti V; Valdivieso M; McCredie KB; Samuels ML
Cancer; 1980 Jun; 45(12):3075-85. PubMed ID: 6992970
[TBL] [Abstract][Full Text] [Related]
60. [Initial results with a epipodophyllotoxin derivative VP 16-213 in the treatment of acute leukemia].
Cavalli F; Ryssel HJ; Batz K; Sonntag RW; Brunner KW
Schweiz Med Wochenschr; 1975 Feb; 105(8):250-3. PubMed ID: 1054886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
